Table 2.
Baseline features of the ischemic population, and differences between CAD (G1) and CMD (G2) patients.
| IHD (N = 272) |
G1 (N = 218) |
G2 (N = 54) |
p-Value | |
|---|---|---|---|---|
| age (years) | 66 ± 12 | 67 ± 12 | 62 ± 13 | 0.001 |
| male gender | 199 | 175 | 24 | <0.001 |
| BMI (kg/m2) | 26.0 ± 2.9 | 26.0 ± 2.9 | 26.1± 2.9 | 0.77 |
| arterial hypertension | 201 | 152 | 49 | 0.001 |
| diabetes mellitus | 74 | 67 | 7 | 0.01 |
| dyslipidemia | 150 | 127 | 23 | 0.04 |
| smoking habit | 114 | 100 | 14 | 0.01 |
| familial history of CV disease | 113 | 96 | 17 | 0.12 |
| AF | 35 | 29 | 6 | 0.66 |
| COPD | 25 | 21 | 4 | 0.46 |
| CKD | 12 | 12 | 0 | 0.13 |
| LVEF (%) | 48 ± 10 | 46 ± 11 | 54 ± 7 | <0.001 |
| rs1799983_GG | 115 | 92 | 23 | 1 |
| rs1799983_GT | 51 | 39 | 12 | 0.47 |
| rs1799983_TT | 106 | 87 | 19 | <0.001 |
IHD: ischemic heart disease; BMI: body mass index; CV: cardiovascular; AF: atrial fibrillation; COPD: chronic obstructive pulmonary disease; CKD: chronic kidney disease; LVEF: left ventricular ejection fraction; rs1799983: polymorphism for the gene nitric oxide synthase 3.